- CA$1.78bn
- CA$735.60m
- $146.59m
Cronos Group Q3 revenue misses expectations
US STOCKS-Wall Street indexes climb as investors brush off government shutdown uncertainties
US STOCKS-S&P 500, Nasdaq climb as investors brush off government shutdown uncertainties
US STOCKS-S&P 500, Nasdaq climb as investors brush off shutdown woes, hawkish talk
Cannabis stocks surge after Trump endorses cannabidiol for senior healthcare (updated)
Cannabis stocks surge after Trump endorses cannabidiol for senior healthcare
Pot stocks jump as Trump signals possible reclassification
Pot stocks climb on report Trump considers reclassifying marijuana as less dangerous
Cannabis company Cronos Q2 revenue up 21% but misses estimates
Cronos rises as it swings to positive net income in Q4
Corrected: BRIEF-Cronos Group Q4 Revenue USD 30.3 Million
Pot stocks fall as DEA cancels cannabis rescheduling hearing
Pot stocks fall as DEA judge cancels hearing on marijuana rescheduling
Pot stocks fall, DEA eyes mid-Jan for cannabis rescheduling hearing
Pot stocks fall after DEA hearing on marijuana reclassification begins
Brief: Cronos Group Q3 Revenue USD 4.268 Million
Pot stocks dive as Florida rejects legalization of recreational marijuana (updated)
Pot stocks dive as Florida rejects legalization of recreational marijuana
Cannabis firms gain as Trump shows support for reclassification